Approval · Notice of Compliance 16103 · 2014
NOCDURNA: Notice of Compliance 16103
Issued September 4, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 16103
- Date
- September 4, 2014
- Company
- Ferring Inc.North York, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Labelling change in dosage for men from the currently approved dosage of 100 mcg once daily to 50 mcg once daily
- Therapeutic class
- Antidiuretic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NOCDURNA | 02431076 | Cancelled Post Market |
Medicinal ingredients
- DESMOPRESSIN ACETATE 50 MCG per TAB